Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat
- PMID: 1360255
- DOI: 10.1007/BF00055608
Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat
Abstract
The purpose of this study was to evaluate the effects of carvedilol, a beta 1&2-adrenergic blocker and vasodilator, on cirazoline-mediated changes in arterial blood pressure and isoproterenol-mediated changes in heart rate after acute and chronic administration. Conscious, chronically instrumented male Sprague-Dawley rats were injected with carvedilol (1 mg/kg, IV), prazosin (0.3 mg/kg, IV), or propranolol (1 mg/kg, twice daily for 8 days. After administration of the first dose of carvedilol on day 1, the vasopressor response to cirazoline (60 +/- 3 mmHg predrug) and the isoproterenol-induced tachycardia (152 +/- 13 beats/min predrug) were blocked (e.g., 7 +/- 4 mmHg postdrug and 11 +/- 3 beats/min postdrug, respectively). After the administration of carvedilol on day 8, the cirazoline vasopressor response was 2 +/- 1 mmHg and the isoproterenol-induced tachycardia was 4 +/- 3 beats/min, indicating effective alpha 1- and beta-adrenergic blockade after chronic dosing with carvedilol. Prazosin blocked the cirazoline-induced vasopressor response on both days 1 and 8 but had no effect on the isoproterenol-induced tachycardia. Propranolol blocked the isoproterenol-induced tachycardia on both days 1 and 8 but had no effect on the cirazoline vasopressor response. These data indicate that only carvedilol effectively blocked both alpha- and beta-adrenergic hemodynamic responses and that the antagonism of these responses with carvedilol was not diminished after chronic dosing of twice-a-day treatment for 8 days.
Similar articles
-
Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.Fundam Clin Pharmacol. 1991;5(1):25-38. doi: 10.1111/j.1472-8206.1991.tb00698.x. Fundam Clin Pharmacol. 1991. PMID: 1712335
-
Alpha 1-blocking properties of carvedilol during acute and chronic administration.J Cardiovasc Pharmacol. 1992;19 Suppl 1:S18-22. doi: 10.1097/00005344-199219001-00005. J Cardiovasc Pharmacol. 1992. PMID: 1378144 Clinical Trial.
-
Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.Am J Vet Res. 2005 Apr;66(4):637-41. doi: 10.2460/ajvr.2005.66.637. Am J Vet Res. 2005. PMID: 15900944
-
Pharmacodynamic profile of carvedilol.Cardiology. 1993;82 Suppl 3:19-23. doi: 10.1159/000175939. Cardiology. 1993. PMID: 8106159 Review.
-
Pharmacology of carvedilol.Am J Cardiol. 2004 May 6;93(9A):3B-6B. doi: 10.1016/j.amjcard.2004.01.003. Am J Cardiol. 2004. PMID: 15144929 Review.